Status:
COMPLETED
The Spectralis-Cirrus Study
Lead Sponsor:
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Conditions:
Exudative Age Related Macular Degeneration
Eligibility:
All Genders
50+ years
Brief Summary
Retinal thickness measurement is one of the most important examinations in the follow up of exudative age-related macular degeneration. Prior studies have shown that there are a series of algorithm li...
Eligibility Criteria
Inclusion
- Exudative age related macular degeneration
Exclusion
- Macular pathologies other than age related macular degeneration (diabetic maculopathy, macular pucker, macular hole,
- Visualization of the macula not possible (dens cataract, vitreous haemorrhage)
- Not consented patients
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00927303
Start Date
July 1 2009
End Date
December 1 2009
Last Update
June 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
Vienna, Vienna, Austria, 1030